Japan Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Japan's Blood Glucose Monitoring Market is Segmented Into Type (Self-Monitoring Blood Glucose, And Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, And Durables). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Japan Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Japan Blood Glucose Monitoring Market Size

View Global Report
Japan Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 0.93 Billion
Market Size (2030) USD 1.31 Billion
CAGR (2025 - 2030) 7.00 %

Major Players

Japan Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Japan Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Japan Blood Glucose Monitoring Market Analysis

The Japan Blood Glucose Monitoring Market size is estimated at USD 0.93 billion in 2025, and is expected to reach USD 1.31 billion by 2030, at a CAGR of 7% during the forecast period (2025-2030).

As of April 2023, the JMDC database housed information from around 16 million patients, encompassing both healthy individuals and a specific subset dedicated to patients with diabetes mellitus. Individuals who have both type 2 diabetes (T2D) and metabolic syndrome are at a higher risk of developing cardiovascular disease in comparison to those with T2D but without metabolic syndrome.

While Type 1 diabetes is caused by an immune system malfunction, Type 2 diabetes is linked to leading a sedentary lifestyle, which results in the development of inherent resistance to insulin. Hence, Type 1 diabetes can be characterized as insulin-requiring, while Type 2 diabetes can be characterized as insulin-dependent diabetes. Japan has one of the largest elderly populations in the world which is more susceptible to the onset of type 2 diabetes. As Japan's population continues to age, the prevalence of diabetes increases as well. The monitoring and management of blood glucose levels are on the rise, to avoid negative consequences, such as cardiovascular diseases, kidney disorders, and many other conditions.

The rising number of diabetes cases in Japan is fueling the growth of the market for blood glucose devices in several ways. Firstly, as the prevalence of diabetes increases, there is a greater demand for blood glucose monitoring devices among individuals with the condition. This has led to an increased adoption of these devices, driving the market growth.

Secondly, the Japanese government has been actively promoting diabetes management and prevention programs, which has further contributed to the growth of the market. These programs often emphasize the importance of regular blood glucose monitoring, leading to an increased awareness and demand for blood glucose devices.

Additionally, advancements in technology have led to the development of more accurate and user-friendly blood glucose devices. These devices often come with features such as wireless connectivity, smartphone integration, and continuous glucose monitoring, making them more convenient and appealing to individuals with diabetes. The availability of such advanced devices has also contributed to the market growth.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Japan Blood Glucose Monitoring Industry Overview

The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players, like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.

Japan Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Abbott

  3. Medtronics

  4. Dexcom

  5. LifeScan

  6. *Disclaimer: Major Players sorted in no particular order
Japan Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Japan Blood Glucose Monitoring Market News

  • June 2023: Kakao Healthcare is set to introduce a diabetes management service powered by Dexcom. As stated in a press release, this collaboration leverages Kakao Healthcare's expertise in AI and software technology, along with Dexcom's advanced continuous glucose monitoring (CGM) devices, namely Dexcom G6 and G7. It is worth noting that Dexcom is currently in the process of obtaining approval from the Ministry of Food and Drug Safety for these devices.
  • May 2022: Terumo announces that the indication for the Dexcom G6 CGM System has changed in Japan. With this new indication, the Dexcom G6 CGM System will be the only real-time continuous glucose monitoring system (RT-CGM) in Japan that can be used principally for the day-to-day management of blood glucose levels without the adjunctive use of a blood glucose meter.

Japan Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring blood glucose devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous blood glucose monitoring devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Functional Medicine
    • 7.1.12 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Japan Blood Glucose Monitoring Industry Segmentation

Japan Blood Glucose Monitoring Market witnessed USD 0.7 billion in the current year and is anticipated to register a CAGR of over 5% during the forecast period. Japan Blood Glucose Monitoring Market is segmented into Type, Component. The report offers the value (in USD) and volume (in Units) for the above segments.

Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

Japan Blood Glucose Monitoring Market Research FAQs

How big is the Japan Blood Glucose Monitoring Market?

The Japan Blood Glucose Monitoring Market size is expected to reach USD 0.93 billion in 2025 and grow at a CAGR of 7% to reach USD 1.31 billion by 2030.

What is the current Japan Blood Glucose Monitoring Market size?

In 2025, the Japan Blood Glucose Monitoring Market size is expected to reach USD 0.93 billion.

Who are the key players in Japan Blood Glucose Monitoring Market?

Roche, Abbott, Medtronics, Dexcom and LifeScan are the major companies operating in the Japan Blood Glucose Monitoring Market.

What years does this Japan Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Japan Blood Glucose Monitoring Market size was estimated at USD 0.86 billion. The report covers the Japan Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Japan Blood Glucose Monitoring Industry Report

Statistics for the 2025 Japan Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.